These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39028668)

  • 1. Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis.
    Jang YH; Choi EY; Lee H; Woo J; Park S; Noh Y; Jeon JY; Yoo EY; Shin JY; Lee YW
    JAMA Netw Open; 2024 Jul; 7(7):e2423563. PubMed ID: 39028668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral corticosteroid exposure and adverse effects in asthmatic patients.
    Sullivan PW; Ghushchyan VH; Globe G; Schatz M
    J Allergy Clin Immunol; 2018 Jan; 141(1):110-116.e7. PubMed ID: 28456623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review.
    Rice JB; White AG; Scarpati LM; Wan G; Nelson WW
    Clin Ther; 2017 Nov; 39(11):2216-2229. PubMed ID: 29055500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure.
    Simpson EL; Silverberg JI; Nosbaum A; Winthrop K; Guttman-Yassky E; Hoffmeister KM; Egeberg A; Valdez H; Fan H; Farooqui SA; Chan G; Alderfer J; Romero W; Chittuluru K
    Am J Clin Dermatol; 2024 Jul; 25(4):639-654. PubMed ID: 38888681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in children with moderate to severe atopic dermatitis.
    van Velsen SG; Knol MJ; van Eijk RL; de Vroede MA; de Wit TC; Lam MG; Haeck IM; de Bruin-Weller MS; Bruijnzeel-Koomen CA; Pasmans SG
    J Am Acad Dermatol; 2010 Nov; 63(5):824-31. PubMed ID: 20850893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.
    Delea TE; Gokhale M; Makin C; Hussein MA; Vanderpoel J; Sandman T; Chang J; Sung J; Pinkston P; Gause D; Jackson M
    J Manag Care Pharm; 2007 May; 13(4):349-59. PubMed ID: 17506601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
    Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
    JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-related adverse events in patients with giant cell arteritis: A claims-based analysis.
    Broder MS; Sarsour K; Chang E; Collinson N; Tuckwell K; Napalkov P; Klearman M
    Semin Arthritis Rheum; 2016 Oct; 46(2):246-252. PubMed ID: 27378247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atopic Eczema-Associated Fracture Risk and Oral Corticosteroids: A Population-Based Cohort Study.
    Matthewman J; Mansfield KE; Prieto-Alhambra D; Mulick AR; Smeeth L; Lowe KE; Silverwood RJ; Langan SM
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1):257-266.e8. PubMed ID: 34571200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Children and the risk of fractures caused by oral corticosteroids.
    van Staa TP; Cooper C; Leufkens HG; Bishop N
    J Bone Miner Res; 2003 May; 18(5):913-8. PubMed ID: 12733732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of clinical and social factors with risk of fracture in children with atopic dermatitis.
    Ha EK; Kim JH; Kwak JH; Lee S; Cha HR; Chung EH; Han MY
    Pediatr Allergy Immunol; 2022 Feb; 33(2):e13712. PubMed ID: 34862671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The population risk of fractures attributable to oral corticosteroids.
    Donnan PT; Libby G; Boyter AC; Thompson P
    Pharmacoepidemiol Drug Saf; 2005 Mar; 14(3):177-86. PubMed ID: 15672413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario.
    Matthewman J; Tadrous M; Mansfield KE; Thiruchelvam D; Redelmeier DA; Cheung AM; Lega IC; Prieto-Alhambra D; Cunliffe LA; Mulick A; Henderson A; Langan SM; Drucker AM
    JAMA Dermatol; 2023 Sep; 159(9):961-969. PubMed ID: 37556153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis.
    Yu SH; Drucker AM; Lebwohl M; Silverberg JI
    J Am Acad Dermatol; 2018 Apr; 78(4):733-740.e11. PubMed ID: 29032119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study of short-term corticosteroid use by working-age adults with diabetes mellitus: Risks and mitigating factors.
    Rogers MAM; Lin P; Nallamothu BK; Kim C; Waljee AK
    J Diabetes; 2018 Jul; 10(7):546-555. PubMed ID: 29193668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.